A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Mouse Models for Graft Arteriosclerosis

13.4K views

⸱

DOI:

10.3791/50290

⸱

May 14th, 2013

 ,  , 

In This Article

Summary

We describe protocols for our mouse graft arteriosclerois (GA) models which involve interposition of a mouse vessel segment into a recipient of the same inbred strain. By backcrossing additional genetic changes into the vessel donor, the model can assess the effect of specific genes on GA.

Abstract

Graft arteriosclerois (GA), also called allograft vasculopathy, is a pathologic lesion that develops over months to years in transplanted organs characterized by diffuse, circumferential stenosis of the entire graft vascular tree. The most critical component of GA pathogenesis is the proliferation of smooth muscle-like cells within the intima. When a human coronary artery segment is interposed into the infra-renal aortae of immunodeficient mice, the intimas could be expand in response to adoptively transferred human T cells allogeneic to the artery donor or exogenous human IFN-γ in the absence of human T cells. Interposition of a mouse aorta from one strain into another mouse strain recipient is limited as a model for chronic rejection in humans because the acute cell-mediated rejection response in this mouse model completely eliminates all donor-derived vascular cells from the graft within two-three weeks. We have recently developed two new mouse models to circumvent these problems. The first model involves interposition of a vessel segment from a male mouse into a female recipient of the same inbred strain (C57BL/6J). Graft rejection in this case is directed only against minor histocompatibility antigens encoded by the Y chromosome (present in the male but not the female) and the rejection response that ensues is sufficiently indolent to preserve donor-derived smooth muscle cells for several weeks. The second model involves interposing an artery segment from a wild type C57BL/6J mouse donor into a host mouse of the same strain and gender that lacks the receptor for IFN-γ followed by administration of mouse IFN-γ (delivered via infection of the mouse liver with an adenoviral vector. There is no rejection in this case as both donor and recipient mice are of the same strain and gender but donor smooth muscle cells proliferate in response to the cytokine while host-derived cells, lacking receptor for this cytokine, are unresponsive. By backcrossing additional genetic changes into the vessel donor, both models can be used to assess the effect of specific genes on GA progression. Here, we describe detailed protocols for our mouse GA models.

Introduction

Graft arteriosclerois (GA), also called allograft vasculopathy, is a pathologic lesion that develops over months to years in transplanted organs characterized by diffuse, circumferential stenosis of the entire graft vascular tree 7. Early stages may cause eccentric and focal stenoses that are more obvious in arteries, thus more closely resembling stenoses seen in conventional atherosclerosis. The lumen loss of the graft vessels results from intimal expansion due to infiltration of host T cells and macrophages and especially to accumulation of extracellular matrix and smooth muscle-like cells originated from graft, host or both 5, 13, 19, that is ....

Access restricted. Please log in or start a trial to view this content.

Protocol

Mouse allograft and syngeneic graft transplantation model

All animal studies were approved by the institutional animal care and use committees of Yale University. For allograft model, segments of thoracic aorta from male, 4-5 week old WT (C57BL/6J) or IFN-γR-KO mice were interposed into the abdominal aorta of female recipient, 8-12 week old WT using an end-to-end microsurgical anastomotic technique (see next for details). For syngeneic graft model, segments of thoracic aortae from male, 4-5 week old WT mice were interposed into the abdominal aortae of male, 8-12 week old IFN-γR1-KO using an end-to-end microsurgical anastomotic tech....

Access restricted. Please log in or start a trial to view this content.

Results

Mouse allograft arteriosclerosis (GA) model: In this model, a male donor aorta is transplanted into female recipient so that the host induces alloreactive T cell-mediated alloimmune responses against a minor Y antigen (the male-specific minor histocompatibility antigen H-Y) expressed on the graft 12, and in turn T cell-produced IFN-γ drives VSMC proliferation 20 as observed in other allograft transplantation models 2, 6, 8-10, 14. A segment of thoracic aorta from a donor .......

Access restricted. Please log in or start a trial to view this content.

Discussion

The described protocols are focused on mouse GA models. The procedures can be applied to other graft transplantation models. These models include humanized xenograft (i.e. human coronary artery segments interposed into the infra-renal aortae of immunodeficient mice), and acute rejection mouse GA model (i.e. a mouse aorta from one genetic strain into another genetic strain recipient). Our described mouse models are more to close human GA lesions. The first model involves interposition of a vessel segment.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

We have nothing to disclose.

Acknowledgements

This work was supported by NIH grants R01 HL109420 to WM and AHA 9320033N to LY.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
C57BL/6J (H-2b)Jackson Laboratories (Bar Harbor, ME)000664Donor (5 weeks)
Recipient (8-12weeks)
Ketamine Hydrochloride Injection Hospira Inc.NDC 0409-2053Storage Solution(50 mg/ml)
Working Solution(5 mg/ml)
Xylazine Sterile SolutionLloyd Inc.NADA# 139-236Storage Solution(100 mg/ml)
Working Solution(1 mg/ml)
KetoprofenFort Dodge Animal HealthNDC 0856-4396-01Storage Solution(100 mg/ml)
Working Solution-oral
(0.027 mg/ml)
Heparin SodiumSagent PharmaceticalsNDC 25021-400Storage Solution(1000 U/ml)
Working Solution(100 U/ml)
Saline solution (Sterile 0.9% Sodium Chloride)CareFusionAL4109
0.9% Sodium Chloride InjectionHospira Inc.NDC 0409-4888-10To prepare the anesthetic
Petrolatum Ophthalmic Ointment Dechra Veterinary ProductsNDC 17033-211-38
Iodine Prep Pads Triad Disposables, Inc.NDC 50730-3201-1
Alcohol Prep PadsMcKesson Corp.NDC 68599-5805-1
MicroscopeLeicaMZ95
Micro ScissorsRoboz Surgical Instrument Co.RS-5693
Spring ScissorsF.S.T15009-08To transect the aorta of donor or recipient
Extra Narrow ScissorsF.S.T14088-10
Needle Holder/ForcepsMICRINSMI1542To hold the needle
Fine ForcepsF.S.T11254-20
ForcepsF.S.T11251-35
Standard Pattern ForcepsF.S.T11000-12
ForcepsF.S.T13011-12
LANCASTER Eye SpeculumZepf Medical Instruments42-1209-07
Micro Vascular ClipRoboz Surgical Instrument Co.RS-6472
Micro Clip Applying Forceps With LockRoboz Surgical Instrument Co.RS-5440
Black Polyamide Monofilament SutureAROSurgical Instruments CorporationCat #T4A10Q0710-0 suture, Needle=70 microns
Black Monofilament Nylon SutureSyneture
(Covidien)
SN-19566-0 suture
Non-Woven SongesMcKesson Corp.Reorder No. 94442000
1 ml SyringeBDREF 309659
3 ml SyringeBDREF 309657
10 ml SyringeBDREF 309604
18G 1 1/2, Hypodermic NeedleBDREF 305196
25G 7/8, Hypodermic NeedleBDREF 305124
27G 1/2, Hypodermic NeedleBDREF 305109
30G 1/2, Hypodermic NeedleBDREF 305106
Hearting PadSunbeamZ-1228-001
TrimmerWahl9854-500
Table 2. Specific reagents and equipment.

References

  1. George, J. F., Pinderski, L. J., Litovsky, S., Kirklin, J. K. Of mice and men: mouse models and the molecular mechanisms of post-transplant coronary artery disease. J. Heart Lung Transplant. 24, 2003-2014 (2005).
  2. Koulack, J., McAlister, V. C., MacAulay, M. A., Bitter-Suermann, H., MacDonald, A. S., Lee, T. D.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Mouse ModelVessel TransplantationAortic AnastomosisInterferon GammaHistological AnalysisHind Limb FunctionHeparinized SalineThoracic Aorta DissectionAbdominal Aorta Exposure